A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Lesion count
- Registration Number
- NCT00989313
- Lead Sponsor
- Peplin
- Brief Summary
This study is designed to follow up patients, who have participated in the PEP005-028 study and observed complete clearance of their Actinic Keratosis (AK) lesions, over a 12 month period to assess both recurrence of AK lesions and long term safety in the selected treatment area.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Lesion count -
- Primary Outcome Measures
Name Time Method Summarize treatment area recurrence of AK lesions, in the selected treatment area during a 12 month follow-up period for patients with complete clearance, who have completed Day 57 in Study PEP005-028. 12 months
- Secondary Outcome Measures
Name Time Method Summarize long-term safety data, in the selected treatment area over a 12 month follow-up period for patients with complete clearance, who have completed Day 57 in Study PEP005-028. 12 months
Trial Locations
- Locations (17)
Burke Pharmaceutical Research
🇺🇸Hot Springs, Arizona, United States
Skin Surgery Medical Group Inc.
🇺🇸San Diego, California, United States
Atlanta Dermatology, Vein & Research Center, LLC
🇺🇸Alpharetta, Georgia, United States
Altman Dermatology Associates
🇺🇸Arlington Heights, Illinois, United States
Glazer Dermatology
🇺🇸Buffalo Grove, Illinois, United States
Deaconess Clinic Downtown
🇺🇸Evansville, Indiana, United States
Dawes Fretzin Clinical Research Group, LLC
🇺🇸Indianapolis, Indiana, United States
Skin Specialists, PC
🇺🇸Omaha, Nebraska, United States
Karl G. Heine Dermatology
🇺🇸Henderson, Nevada, United States
Group Health Associates
🇺🇸Cincinnati, Ohio, United States
Scroll for more (7 remaining)Burke Pharmaceutical Research🇺🇸Hot Springs, Arizona, United States